Diversified Product Range Acro Biotech offers a broad portfolio of rapid tests, including USFDA-approved diagnostic products for women's health, cardiac markers, tumor markers, and infectious diseases, presenting multiple opportunities to supply additional specialized test kits and expand product lines.

Regulatory Compliance Expertise With ISO 13485:2003 and CMDCAS accreditation, Acro Biotech emphasizes high-quality manufacturing standards, making it a reliable partner for healthcare providers and distributors seeking compliant and certified rapid diagnostic solutions.

Market Expansion Potential Targeting international markets with diverse infectious disease tests positions Acro Biotech for growth in emerging regions, where rapid diagnostic testing demand is increasing due to global health initiatives.

Technology Infrastructure Utilizing advanced tech stacks such as Google Cloud CDN and Sentry indicates operational efficiency and scalable digital infrastructure, which can support expansion, automation, and integration of new diagnostic technologies.

Collaborative Growth With a seasoned team of industry veterans and alignment with larger firms like Thermo Fisher and Bio-Rad in the medical equipment space, Acro Biotech can leverage partnerships and knowledge sharing to accelerate product innovation and distribution networks.